FDA Approves First Oral PCSK9 Inhibitor to Lower LDL Cholesterol in Adults with High Cholesterol
- FDA News Release First oral PCSK9 inhibitor provides an additional treatment option for adults with hypercholesterolemia For Immediate Release: July 17, 2026 The U.
- PCSK9 inhibitors have previously been available only as injectable t
Unverified
- FDA News Release First oral PCSK9 inhibitor provides an additional treatment option for adults with hypercholesterolemia For Immediate Release: July 17, 2026 The U.
- PCSK9 inhibitors have previously been available only as injectable t
Sources: Fda